欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/0116/002
药品名称
Diastabol 100 mg
活性成分
miglitol 100.0 mg
剂型
Tablet
上市许可持有人
Sanofi-Aventis Netherlands B.V. Kampenringweg 45 D-E 2803 PE Gouda
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
许可日期
1997/12/03
最近更新日期
2020/05/27
药物ATC编码
A10BF Alpha glucosidase inhibitors
申请类型
TypeLevel1:
New Active Substance
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Full Dossier Article 4.8 Di 65/65
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
common_combined_pi_diastabol50_100envar027en_clean_EoP
Date of last change:2024/09/06
Final PL
|
common_pl_diastabol100envar23clean26nov2012
Date of last change:2024/09/06
Final PL
|
common_pl_diastabol50envar23clean26nov2012
Date of last change:2024/09/06
Final SPC
|
common_spc_diastabolenvar22annotated21oct2010
Date of last change:2024/09/06
市场状态
Withdrawn(注:已撤市)
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase